The U.S. Department of Health and Human Services (HHS) has recommended the DEA to reclassify marijuana from Schedule I to Schedule III. The Congressional Research Service (CRS) report suggests the DEA may follow the HHS's recommendation. This could lead to federal tax benefits for marijuana businesses, legally sanction medical marijuana's manufacture, distribution, and possession, and expand rights for medical cannabis users. However, the final decision lies with Congress. Verano Holdings Corp. (OTCQX:VRNOF) CEO, George Archos, sees this as a positive moment for the cannabis industry.